These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 22305413)

  • 21. Epidemiological and clinical features associated with colonisation/infection by Acinetobacter baumannii with phenotypic heterogeneous resistance to carbapenems.
    Fernández-Cuenca F; Gómez-Sánchez M; Rodríguez-Baño J; Martínez-Martínez L; Vila J; Bou G; Pascual A
    Int J Antimicrob Agents; 2012 Sep; 40(3):235-8. PubMed ID: 22784855
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biofilm formation by Acinetobacter baumannii strains isolated from urinary tract infection and urinary catheters.
    Pour NK; Dusane DH; Dhakephalkar PK; Zamin FR; Zinjarde SS; Chopade BA
    FEMS Immunol Med Microbiol; 2011 Aug; 62(3):328-38. PubMed ID: 21569125
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of tigecycline in the control of a carbapenem-resistant Acinetobacter baumannii outbreak in an intensive care unit.
    Jamal W; Salama M; Dehrab N; Al Hashem G; Shahin M; Rotimi VO
    J Hosp Infect; 2009 Jul; 72(3):234-42. PubMed ID: 19493588
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II.
    Nemec A; Krízová L; Maixnerová M; Diancourt L; van der Reijden TJ; Brisse S; van den Broek P; Dijkshoorn L
    J Antimicrob Chemother; 2008 Sep; 62(3):484-9. PubMed ID: 18477708
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of carbapenem-resistant Acinetobacter from a tertiary care setting in North India.
    Sinha N; Agarwal J; Srivastava S; Singh M
    Indian J Med Microbiol; 2013; 31(1):60-3. PubMed ID: 23508431
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular characterisation of multiple drug-resistant Acinetobacter baumannii isolates in southern Taiwan.
    Ben RJ; Yang MC; Hsueh JC; Shiang JC; Chien ST
    Int J Antimicrob Agents; 2011 Nov; 38(5):403-8. PubMed ID: 21871784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ESBL- and MBL-mediated resistance in Acinetobacter baumannii: a global threat to burn patients.
    Owlia P; Azimi L; Gholami A; Asghari B; Lari AR
    Infez Med; 2012 Sep; 20(3):182-7. PubMed ID: 22992558
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nosocomial Infections Caused by Acinetobacter baumannii: Are We Losing the Battle?
    Protic D; Pejovic A; Andjelkovic D; Djukanovic N; Savic D; Piperac P; Markovic Denic L; Zdravkovic M; Todorovic Z
    Surg Infect (Larchmt); 2016 Apr; 17(2):236-42. PubMed ID: 26885722
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carbapenem-resistant Acinetobacter baumannii producing OXA-23 in Thailand.
    Niumsup PR; Boonkerd N; Tansawai U; Tiloklurs M
    Jpn J Infect Dis; 2009 Mar; 62(2):152-4. PubMed ID: 19305059
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Investigation of colistin sensitivity via three different methods in Acinetobacter baumannii isolates with multiple antibiotic resistance.
    Sinirtaş M; Akalin H; Gedikoğlu S
    Int J Infect Dis; 2009 Sep; 13(5):e217-20. PubMed ID: 19230734
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Postantibiotic effects of tigecycline, colistin sulfate, and levofloxacin alone or tigecycline-colistin sulfate and tigecycline-levofloxacin combinations against Acinetobacter baumannii.
    Ozbek B; Sentürk A
    Chemotherapy; 2010; 56(6):466-71. PubMed ID: 21088399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Colistin against colistin-only-susceptible Acinetobacter baumannii-related infections: Monotherapy or combination therapy?
    Simsek F; Gedik H; Yildirmak MT; Iris NE; Türkmen A; Ersoy A; Ersöz M; Gücüyener A
    Indian J Med Microbiol; 2012; 30(4):448-52. PubMed ID: 23183471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro activities of colistin and ampicillin/sulbactam against Acinetobacter baumannii.
    Punpanich W; Munsrichoom A; Srisarang S; Treeratweeraphong V
    J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S95-100. PubMed ID: 22043760
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Secular trends in Acinetobacter baumannii resistance in respiratory and blood stream specimens in the United States, 2003 to 2012: A survey study.
    Zilberberg MD; Kollef MH; Shorr AF
    J Hosp Med; 2016 Jan; 11(1):21-6. PubMed ID: 26353076
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A multicenter study of risk factors and outcome of hospitalized patients with infections due to carbapenem-resistant Acinetobacter baumannii.
    Sheng WH; Liao CH; Lauderdale TL; Ko WC; Chen YS; Liu JW; Lau YJ; Wang LH; Liu KS; Tsai TY; Lin SY; Hsu MS; Hsu LY; Chang SC
    Int J Infect Dis; 2010 Sep; 14(9):e764-9. PubMed ID: 20646946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Eradication of multidrug-resistant Acinetobacter baumannii from the respiratory tract with inhaled colistin methanesulfonate: a matched case-control study.
    Kuo SC; Lee YT; Yang SP; Chen CP; Chen TL; Hsieh SL; Siu LK; Fung CP
    Clin Microbiol Infect; 2012 Sep; 18(9):870-6. PubMed ID: 21999321
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of vancomycin in addition with colistin and meropenem against colistin-sensitive multidrug resistant Acinetobacter baumannii causing severe infections in a Paediatric Intensive Care Unit.
    Ceccarelli G; Oliva A; d'Ettorre G; D'Abramo A; Caresta E; Barbara CS; Mascellino MT; Papoff P; Moretti C; Vullo V; Visca P; Venditti M
    BMC Infect Dis; 2015 Sep; 15():393. PubMed ID: 26424078
    [TBL] [Abstract][Full Text] [Related]  

  • 38. OXA-72-Mediated Carbapenem Resistance in Sequence Type 1 Multidrug (Colistin)-Resistant Acinetobacter baumannii Associated with Urinary Tract Infection in a Dog from Serbia.
    Misic D; Asanin J; Spergser J; Szostak M; Loncaric I
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29760134
    [No Abstract]   [Full Text] [Related]  

  • 39. High rate of colistin dependence in Acinetobacter baumannii.
    Hong YK; Lee JY; Wi YM; Ko KS
    J Antimicrob Chemother; 2016 Aug; 71(8):2346-8. PubMed ID: 27076109
    [No Abstract]   [Full Text] [Related]  

  • 40. Annual trends in antibiotic resistance of nosocomial Acinetobacter baumannii strains and the effect of synergistic antibiotic combinations.
    Tatman-Otkun M; Gürcan S; Ozer B; Shokrylanbaran N
    New Microbiol; 2004 Jan; 27(1):21-8. PubMed ID: 14964402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.